Search Within

Solid Tumor Oncology Division

  1. "Clifford Hudis"
Formats
  1. Journal Article (483)
  2. Meeting Abstract (393)
  3. Book Section (15)
  4. Conference Paper (10)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Review (1)
Groups
  1. Breast Medicine Service (905)
  2. Department of Medicine (905)
  3. Survivorship Research (905)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (318)
  5. Epidemiology and Biostatistics (242)
  6. Biostatistics Service (221)

More Groups

People
  1. Clifford Hudis (905)
  2. Larry Norton (293)
  3. Sujata Patil (141)
  4. Andrew Seidman (116)
  5. Chau Dang (111)
  6. Maura Dickler (102)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (4)
  5. 2020 (5)
  6. 2019 (9)

More Years

Publications
  1. Journal of Clinical Oncology (246)
  2. Cancer Research (108)
  3. Breast Cancer Research and Treatment (77)
  4. Clinical Cancer Research (33)
  5. Cancer (30)
  6. Annals of Oncology (29)

More Publications

Publishers
  1. American Society of Clinical Oncology (249)
  2. American Association for Cancer Research (163)
  3. Springer (100)
  4. Elsevier Inc. (84)
  5. Oxford University Press (55)
  6. Wiley Blackwell (45)

More Publishers

Results (905)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nanoparticle albumin-bound paclitaxel in 3 dosing schedules with bevacizumab as first line therapy for HER2-negative metastatic breast cancer: An interim safety analysis
    Meeting Abstract

    Seidman, A. D.; Conlin, A. K.; Moynahan, M. E.; Bach, A.; Troso-Sandoval, T.; Sugarman, S.; Forero, A.; Kerr, R.; Wright, G.; Hudis, C. A.
    EJC Supplements (2008)

    Fulltext@MSK | Save
  • Tanespimycin (17-allylamino-17-demethoxy-geldanamycin; 17-AAG) in breast cancer
    Meeting Abstract

    Modi, S.; Sugarman, S.; Stopeck, A.; Linden, H.; Ma, W.; Chandarlapaty, S.; Solit, D.; Norton, L.; Rosen, N.; Kersey, K.; more...
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2 overexpressed/amplified breast cancer (BC): First safety results
    Meeting Abstract

    Dang, C.; Lin, N.; Lake, D.; Theodoulou, M.; Drullinsky, P.; Gorsky, M.; Chen, C.; Norton, L.; Winer, E.; Hudis, C.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Racial differences in clinical outcomes from metastatic breast cancer: A pooled analysis of CALGB 9342 and 9840 - Cancer and Leukemia Group B
    Journal Article

    Polite, B. N.; Cirrincione, C.; Fleming, G. F.; Berry, D. A.; Seidman, A.; Muss, H.; Norton, L.; Shapiro, C.; Bakri, K.; Marcom, K.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group n9831 adjuvant breast cancer trial
    Journal Article

    Perez, E. A.; Suman, V. J.; Davidson, N. E.; Sledge, G. W.; Kaufman, P. A.; Hudis, C. A.; Martino, S.; Gralow, J. R.; Dakhil, S. R.; Ingle, J. N.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Aromatase inhibitor-associated musculoskeletal symptoms: Etiology and strategies for management - The Henry/Giles/Stearns Article reviewed
    Journal Article

    Murphy, C.; Hudis, C. A.; Dickler, M. N.
    Oncology (Norwalk) (2008)

    Fulltext@MSK | Save
  • Genetically guided choices for chemotherapy - Reply
    Journal Article

    Hudis, C. A.; Modi, S.
    JAMA - Journal of the American Medical Association (2008)

    Fulltext@MSK | Save
  • Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage II-III breast cancer: Treatment intervals and clinical outcomes
    Journal Article

    Wright, J. L.; Cordeiro, P. G.; Ben-Porat, L.; Van Zee, K. J.; Hudis, C.; Beal, K.; McCormick, B.
    International Journal of Radiation Oncology, Biology, Physics (2008)

    Fulltext@MSK | Save
  • Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer
    Journal Article

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Tan, L. K.; Edwards, C.; Dugan, U.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
    Journal Article

    Traina, T. A.; Poggesi, I.; Robson, M.; Asnis, A.; Duncan, B. A.; Heerdt, A.; Dang, C.; Lake, D.; Moasser, M.; Panageas, K.; more...
    Breast Cancer Research and Treatment (2008)

    Fulltext@MSK | Save